Boehringer Ingelheim gets CDSCO nod for Jardiance to treat for new heart failure indication, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

Jardiance is the top selling drug of BI in India, used in treatment of type-2 diabetes and for the treatment of heart failure with reduced ejection fraction (HFrEF). The latest approval by CDSCO is for the treatment of heart failure with preserved ejection fraction (HFpEF)., Jardiance is the top selling drug of BI in India, used in treatment of type-2 diabetes and for the treatment of heart failure with reduced ejection fraction (HFrEF). The latest approval by CDSCO is for the treatment of heart failure with preserved ejection fraction (HFpEF)., , Read More